Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity using Advanced Imaging Modality Arthroscopy: A Prospective Randomized Trial

Brief description of study

The purpose of this study is to determine the optimal dosing of an injectable fluorescent pigment, Indocyanine Green (ICG), for use during rotator cuff surgeries. ICG is a substance that binds to proteins in the blood and allows surgery teams to view blood vessels with greater precision.

Clinical Study Identifier: s18-01995

ClinicalTrials.gov Identifier: NCT04340752

Principal Investigators: Kirk A Campbell, iConnect Langone.

Other Investigators: Eric J Strauss, Guillem Gonzalez-Lomas, Mandeep S. Virk, Jovan Popovic, Michael J Alaia, Laith M Jazrawi.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies